Fuminori Taniguchi

ORCID: 0000-0001-6922-0632 · 131 papers in corpus
guideline 2023
·doi:10.60692/3zxsn-ep687

This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.

guideline 2023
·doi:10.60692/bx9f2-cbt30

This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.

guideline 2023
Reproductive medicine and biology ·doi:10.1002/rmb2.12535

This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.

observational 2023
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15741

AIM: This study aimed to compare introduced robotic-assisted hysterectomy (RAH) and skilled total laparoscopic hysterectomy (TLH) for the treatment of benign gynecological diseases. METHODS: Patients who underwent RAH or TLH by two surgeon…

guideline 2022
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15416

More than 10 years following the publication of "The General Rules for Clinical Management of Endometriosis: The second edition" in January 2010, the long-awaited third edition has arrived. The second edition represents the bible for endome…

case-report 2022

Uterine adenomyosis is an estrogen-dependent tumor and one of the most common benign diseases in sexually mature women. The frequency of endometrial cancer associated with adenomyosis has been reported to be 18%–66%. On the other hand, endo…

case-report 2022
Yonago acta medica ·doi:10.33160/yam.2022.02.009

Uterine adenomyosis is an estrogen-dependent tumor and one of the most common benign diseases in sexually mature women. The frequency of endometrial cancer associated with adenomyosis has been reported to be 18%-66%. On the other hand, endo…

2022
·doi:10.1007/978-3-030-97236-3_40
review 2022
Reproductive medicine and biology ·doi:10.1002/rmb2.12473

BACKGROUND: Reproductive-age women occasionally face the pathological condition of adenomyosis, which is often concurrent with endometriosis. It is believed that endometriosis and adenomyosis increases the risk of obstetric complications. A…

lab-animal 2022
·doi:10.1210/jendso/bvac150.1359

Abstract Background Endometriosis has been accepted as an estrogen-dependent disease for more than two decades. So far, estrogen modulators that targeting estrogen depletion in endometriotic lesions have been expected as the first option of…

case-report 2022
Yonago acta medica ·doi:10.33160/yam.2022.11.003

We report a case of robot-assisted total hysterectomy in a patient with extremely rare pelvic anatomy. Robot-assisted total laparoscopic hysterectomy was performed for lobular endocervical glandular hyperplasia on the left side of the uteru…

lab-animal 2022
Experimental animals ·doi:10.1538/expanim.21-0146

The pathogenesis of endometriosis has not been fully elucidated. We focused on the behavior of the ectopic endometrium, that is, the origin of the endometriotic lesion, before adhering to the peritoneal cavity. To observe lesion formation i…

lab-animal 2022
Scientific reports ·doi:10.1038/s41598-022-11891-5

Endometriosis, which exhibits enigmatic pathological features such as stromal fibrosis and proliferation of ectopic epithelial cells, is known as a refractory disease. Mesenchymal stem cells modulate the fibrosis in stromal tissues through …

case-report 2021
Yonago acta medica ·doi:10.33160/yam.2021.05.004

Accessory and Cavitated Uterine Mass (ACUM) is a condition defined by the presence of a non-communicating uterine mass close to the insertion of the round ligament. ACUM is a rare Müllerian anomaly found in young women and is diagnosed by t…

rct 2021
Reproductive medicine and biology ·doi:10.1002/rmb2.12408

PURPOSE: To evaluate the efficacy of two progestins, levonorgestrel intrauterine system (LNG-IUS) and dienogest (DNG), for adenomyosis. METHODS: This study enrolled 157 women with adenomyosis, randomized to either LNG-IUS (n = 76) or DNG (…

observational 2021
·doi:10.3390/endocrines2030027

A low dose of dienogest (DNG) 1 mg/day is useful for treating dysmenorrhea in young women. However, the effect of DNG on bone turnover during bone growth and formation, rather than at maturity, is currently unknown even at low doses. We inv…

lab-animal 2021
·doi:10.1210/jendso/bvab048.1566

Abstract Background: Endometriosis is an estrogen-dependent disease, and the role of estrogen is obvious because the symptoms associated with endometriosis often disappear after menopause, and GnRH agonists or progestin relieve the pelvic l…

observational 2021
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14656

AIM: We aimed to describe the clinical presentation, operative or medical management, and postoperative recurrence of bladder endometriosis (BE). METHODS: We conducted a national survey to investigate BE cases from 2006 to 2016 in Japan. H…

observational 2021
·doi:10.5180/jsgoe.37.2_1

Purpose: To verify the efficacy of the endometriosis fertility index (EFI) for predicting spontaneous pregnancy after surgery for endometriosis.

lab-animal 2021
·doi:10.21203/rs.3.rs-855777/v1

Abstract Endometriosis, which exhibits enigmatic pathological features such as stromal fibrosis and proliferation of ectopic epithelial cells, is known as a refractory disease. Mesenchymal stem cells modulate the fibrosis in stromal tissues…

other 2020
Frontiers in bioscience (Elite edition) ·doi:10.2741/871

Endometriosis results from the aberrant growth of endometrium outside the inner lining of the uterine cavity. Similar to humans, the primates also menstruate and hence, the primate models constitute the gold standard for studying the pathog…

observational 2020
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14244

AIM: Endometriosis mostly affects the ovary but can also be present outside of the ovary including the pelvic peritoneum, intestine, urinary tract and lung. In case of ovarian endometriotic cyst, an increased risk of ovarian cancer, especia…

guideline 2020
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14522

The aim of this publication is to disseminate the clinical practice guidelines for the treatment of intestinal, bladder/ureteral, thoracic and umbilical endometriosis, already published in Japanese, to non-Japanese speakers. For developing …

other 2020
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14424

AIM: Tokishakuyakusan (TSS) is representative of popular Kampo medicines for Japanese women to treat dysmenorrhea, irregular menstruation and menopause. Current hormonal treatments and low-dose oral contraceptives (OCs) used as a first-choi…

2020
·doi:10.1210/jendso/bvaa046.576

Abstract BACKGROUND: Endometriosis is an estrogen-dependent, inflammatory disease, and the role of estrogen is obvious because the symptoms associated with endometriosis often disappear after menopause, and GnRH agonists or progestin reliev…